These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Systemic Autoinflammatory Diseases: A Growing Family of Disorders of Overlapping Immune Dysfunction. Gutierrez MJ; Lapidus SK Rheum Dis Clin North Am; 2022 Feb; 48(1):371-395. PubMed ID: 34798958 [TBL] [Abstract][Full Text] [Related]
43. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons]. Günther C; Schmidt F; König N; Lee-Kirsch MA Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186 [TBL] [Abstract][Full Text] [Related]
44. New data in causes of autoinflammatory diseases. Kone-Paut I; Georgin-Laviallec S; Galeotti C; Rossi-Semerano L; Hentgen V; Savey L; Saadoun D; Sarrabay G; Touitou I Joint Bone Spine; 2019 Oct; 86(5):554-561. PubMed ID: 30471422 [TBL] [Abstract][Full Text] [Related]
46. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Szekanecz Z; McInnes IB; Schett G; Szamosi S; Benkő S; Szűcs G Nat Rev Rheumatol; 2021 Oct; 17(10):585-595. PubMed ID: 34341562 [TBL] [Abstract][Full Text] [Related]
47. Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Zhong Z; Su G; Kijlstra A; Yang P Prog Retin Eye Res; 2021 Jan; 80():100866. PubMed ID: 32422390 [TBL] [Abstract][Full Text] [Related]
48. Dermatologic Manifestations of Monogenic Autoinflammatory Diseases. Shwin KW; Lee CR; Goldbach-Mansky R Dermatol Clin; 2017 Jan; 35(1):21-38. PubMed ID: 27890235 [TBL] [Abstract][Full Text] [Related]
49. Autoinflammatory syndromes for the dermatologist. Dávila-Seijo P; Hernández-Martín A; Torrelo A Clin Dermatol; 2014; 32(4):488-501. PubMed ID: 25017460 [TBL] [Abstract][Full Text] [Related]
55. Phenotype variability of autoinflammatory disorders in the pediatric patient: A pictorial overview. Rigante D J Evid Based Med; 2020 Aug; 13(3):227-245. PubMed ID: 32627322 [TBL] [Abstract][Full Text] [Related]
56. Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines. Andretto V; Dusi S; Zilio S; Repellin M; Kryza D; Ugel S; Lollo G Adv Drug Deliv Rev; 2023 Oct; 201():115080. PubMed ID: 37660747 [TBL] [Abstract][Full Text] [Related]
57. RBP-RNA interactions in the control of autoimmunity and autoinflammation. Liu J; Cao X Cell Res; 2023 Feb; 33(2):97-115. PubMed ID: 36599968 [TBL] [Abstract][Full Text] [Related]
58. Type I interferonopathies--an expanding disease spectrum of immunodysregulation. Lee-Kirsch MA; Wolf C; Kretschmer S; Roers A Semin Immunopathol; 2015 Jul; 37(4):349-57. PubMed ID: 25998914 [TBL] [Abstract][Full Text] [Related]
59. The body against self: autoinflammation and autoimmunity. Borella E; Palma L; Zen M; Bettio S; Nalotto L; Gatto M; Domeneghetti M; Laccarino L; Punzi L; Doria A Isr Med Assoc J; 2014 Oct; 16(10):608-10. PubMed ID: 25438443 [No Abstract] [Full Text] [Related]